Healthcare provider profile · identity verified

Drew Anthony Durbin, D.O.

Internal Medicine · PHOENIX, AZ · NPI 1063440907

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	370	115
Amlodipine Besylate	Amlodipine Besylate	325	104
Lisinopril	Lisinopril	295	90
Levothyroxine Sodium	Levothyroxine Sodium	238	74
Escitalopram Oxalate	Escitalopram Oxalate	236	71
Losartan Potassium	Losartan Potassium	213	69
Alprazolam	Alprazolam	202	43
Metformin Hcl	Metformin Hcl	198	63
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	136	20
Tamsulosin Hcl	Tamsulosin Hcl	129	41
Gabapentin	Gabapentin	127	29
Omeprazole	Omeprazole	125	41
Simvastatin	Simvastatin	111	31
Metoprolol Succinate	Metoprolol Succinate	108	30
Rosuvastatin Calcium	Rosuvastatin Calcium	106	34
Lorazepam	Lorazepam	105	21
Ozempic	Semaglutide	105	22
Albuterol Sulfate Hfa	Albuterol Sulfate	98	33
Pantoprazole Sodium	Pantoprazole Sodium	98	27
Hydrochlorothiazide	Hydrochlorothiazide	90	27
Fluoxetine Hcl	Fluoxetine Hcl	81	22
Atenolol	Atenolol	79	24
Famotidine	Famotidine	78	28
Trazodone Hcl	Trazodone Hcl	76	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	75	11
Bupropion Xl	Bupropion Hcl	72	17
Clopidogrel	Clopidogrel Bisulfate	65	23
Metoprolol Tartrate	Metoprolol Tartrate	65	20
Carvedilol	Carvedilol	64	17
Zolpidem Tartrate	Zolpidem Tartrate	61	15
Tramadol Hcl	Tramadol Hcl	60	13
Finasteride	Finasteride	58	17
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	54	suppressed
Furosemide	Furosemide	53	16
Pravastatin Sodium	Pravastatin Sodium	53	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	14
Azithromycin	Azithromycin	46	40
Potassium Chloride	Potassium Chloride	46	14
Montelukast Sodium	Montelukast Sodium	43	14
Eliquis	Apixaban	41	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	31
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	12
Amoxicillin	Amoxicillin	37	32
Nifedipine Er	Nifedipine	37	11
Methylprednisolone	Methylprednisolone	36	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	12
Allopurinol	Allopurinol	33	12
Clonazepam	Clonazepam	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	11
Doxycycline Hyclate	Doxycycline Hyclate	31	17
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Testosterone Cypionate	Testosterone Cypionate	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Prednisone	Prednisone	29	12
Pregabalin	Pregabalin	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	27	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	14
Ondansetron Hcl	Ondansetron Hcl	24	11
Diazepam	Diazepam	23	suppressed
Estradiol	Estradiol	23	suppressed
Fentanyl	Fentanyl	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Temazepam	Temazepam	23	suppressed
Cephalexin	Cephalexin	22	13
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Fluconazole	Fluconazole	21	14
Metformin Hcl Er	Metformin Hcl	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Valsartan	Valsartan	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Sertraline Hcl	Sertraline Hcl	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Glipizide	Glipizide	17	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	14
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Dutasteride	Dutasteride	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Fluticasone Propionate	Fluticasone Propionate	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Minoxidil	Minoxidil	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error